H. Tanaka et al., Calcium channel antagonistic effects of AH-1058, a novel antiarrhythmic drug, on guinea-pig myocardium, RES COM M P, 104(1), 1999, pp. 13-21
Citations number
9
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
Effects of AH-1058, a novel cyproheptadine derivative with high antiarrhyth
mic activity in in vivo arrhythmia models, were studied in guinea-pig myoca
rdium. In coronary-perfused right ventricular tissue preparations, AH-1058
(10(-5)M) shortened the action potential duration with little effect on the
resting membrane potential, maximum rate of rise and overshoot. AH-1058, 1
0(-7) M to 10(-5) M, concentration-dependently decreased the contractile fo
rce. The increase in contractile force by Ca2+ was markedly inhibited by 3
x 10(-6) M AH-1058 while that by isoproterenol was only slightly affected.
In isolated ventricular myocytes, AH-1058 concentration-dependently decreas
ed the nicardipine sensitive transient inward current with no effect on ste
ady state currents, and decreased the amplitude of the evoked Ca2+ transien
t. These results suggest that AH-1058 has Ca2+ channel antagonistic effects
which may contribute to its antiarrhythmic activity.